NCT02264145View on ClinicalTrials.gov

The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

December 31, 1998

Conditions
Healthy
Interventions
DRUG

Ethanolic Solution From HFA134a-MDI - low

DRUG

Ethanolic Solution From HFA134a-MDI - medium

DRUG

Ethanolic Solution From HFA134a-MDI - high

DRUG

Ethanolic Solution From Respimat®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY